We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+36.02%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$334M
AUM Growth
+$107M
Cap. Flow
+$48M
Cap. Flow %
14.36%
Top 10 Hldgs %
34.01%
Holding
80
New
29
Increased
13
Reduced
13
Closed
20

Top Buys

Rank Stock Value
1
LHCG
LHC Group LLC
LHCG
+$11M
2
CRL icon
Charles River Laboratories
CRL
+$8.78M
3
COR icon
Cencora
COR
+$8.29M
4
NUVA
NuVasive, Inc.
NUVA
+$7.23M
5
MOH icon
Molina Healthcare
MOH
+$6.81M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$10.4M
2
CNC icon
Centene
CNC
+$10.1M
3
EHC icon
Encompass Health
EHC
+$7.36M
4
MASI
Masimo
MASI
+$6.2M
5
NVS icon
Novartis
NVS
+$5.77M

Sector Composition

Rank Sector Weight
1 Healthcare 86.88%
2 Energy 6.53%
3 Technology 0.84%
4 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
76
Novartis
NVS
$294B
– –
-70,000
Closed -$5.77M
TXG icon
77
10x Genomics
TXG
$7.62B
– –
-40,000
Closed -$2.49M
UNH icon
78
UnitedHealth
UNH
$365B
– –
-10,000
Closed -$2.49M
XRAY icon
79
Dentsply Sirona
XRAY
$2.31B
– –
-100,000
Closed -$3.88M
PFNX
80
DELISTED
Pfenex Inc.
PFNX
– –
-85,000
Closed -$750K
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Integral Health Asset Management held 80 positions worth $334M, up 47% from $227M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Integral Health Asset Management deployed $48M of net new capital in Q2 2020, opening 29 new positions and adding to 13 existing holdings. Its largest new stake was Charles River Laboratories: 55,000 shares worth $9.59M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 89% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Merck, an estimated $4.34M trimmed.

  • Integral Health Asset Management's largest Q2 2020 buy was Charles River Laboratories: 55,000 shares worth $9.59M.
  • Integral Health Asset Management added most to LHC Group LLC in Q2 2020, an estimated $11M increase.
  • Integral Health Asset Management's biggest Q2 2020 reduction was Merck, cutting an estimated $4.34M.
  • Integral Health Asset Management fully exited Medtronic in Q2 2020, selling an estimated $10.4M.
  • Integral Health Asset Management's ten largest holdings make up 34% of its $334M portfolio in Q2 2020.
  • Integral Health Asset Management opened 29 new positions and closed 20 in Q2 2020.
  • Integral Health Asset Management's portfolio value rose 47% quarter-over-quarter to $334M.

Based on Integral Health Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.